OQROGet OQRO Pro
Insider trade

Sotera Health (SHC)Director sold ~$159M

Pincus & Co. Warburg, Director at Sotera Health, sold ~$159M of Sotera Health shares.

~$159M
Approx. value · 9.72M sh @ $16.33
34.1M
Holds after · shares reported
Traded
Dec 3, 2025
Filed
Dec 6, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
  2. Nov 10, 2025Insider · 2 peopleInsiders: 2 sales (~$469.5M)
  3. Dec 3, 2025 · this disclosureInsiderDirector sold ~$159M of SHC shares in the open market

What came next

  1. Dec 3, 2025InsiderDirector sold ~$106M of SHC shares in the open market
  2. Dec 8, 2025Insider · 1 personInsiders: 3 sales (~$12.3M)
  3. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  4. Feb 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 4, 2026, the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) increased the size of the Board from eleven directors to twelve directors and appointed Richard G. Kyle as a Class III director of the Board, effective immediately.”
  5. Feb 18, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On February 18, 2026, Alex Dimitrief, Senior Vice President and General Counsel of the Company, provided notice to the Company that he will retire on March 31, 2026.”
  6. Mar 6, 2026Insider · 2 peopleInsiders: 2 sales (~$381.8M)
  7. Mar 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 12, 2026, as a result of a reduction in the number of directors that certain stockholders are entitled to designate for election to the Board of Directors (the “Board”) of Sotera Health Company (the “Company”), Constantine S. Mihas notified the Board of his intention to resign as a Class I director, effective March 16, 2026.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Sotera Health

For Sotera Health, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SHC page.

Other recent filings by Pincus & Co. Warburg, Director

The full history of Pincus & Co. Warburg, Director is on the profile page.

How this filing works

Other disclosures at Sotera Health

Everything OQRO holds on this company is on its SHC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data